Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mico Biomed Co. Ltd. (214610:KRX), powered by AI.
Mico Biomed Co. Ltd. is currently trading at ₩2,290. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Mico Biomed Co. Ltd. on Alpha Lenz.
Mico Biomed Co. Ltd.'s P/E ratio is -0.3.
“Mico Biomed Co. Ltd. trades at a P/E of -0.3 (undervalued) with modest ROE of -98.1%.”
Ask for details →Mico Biomed Co. Ltd. is a prominent player in the biotechnology industry, specializing in the development and manufacturing of diagnostic solutions. The company's primary function involves the innovation and production of highly precise medical diagnostic devices and kits. These products are crucial for detecting and monitoring various diseases and conditions, offering significant contributions to healthcare provisioning and patient outcomes. Mico Biomed's offerings cater to a wide spectrum of needs within both clinical and point-of-care settings, allowing for timely and accurate diagnosis, which is essential for effective treatment planning. The company is known for its dedication to research and development, ensuring that its product lines remain at the forefront of technological advancements. By focusing on enhancing the accessibility and reliability of medical diagnostics, Mico Biomed Co. Ltd. holds a vital role in the healthcare sector, contributing to improved public health standards and supporting the broader medical industry in addressing healthcare challenges.
“Mico Biomed Co. Ltd. trades at a P/E of -0.3 (undervalued) with modest ROE of -98.1%.”
Ask for details →Mico Biomed Co. Ltd. (ticker: 214610) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 50 employees. Market cap is $19.2B.
The current price is ₩2,290 with a P/E ratio of -0.32x and P/B of 0.39x.
ROE is -98.14% and operating margin is -414.43%. Annual revenue is $4.6B.